BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 25914462)

  • 1. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
    Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
    World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
    Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
    BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats.
    Yang C; Zhang SS; Li XL; Wang ZF; Zhao LQ
    World J Gastroenterol; 2015 Mar; 21(10):2912-7. PubMed ID: 25780288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
    Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
    World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alleviating pain effect of aqueous extract from tong-xie-yao-fang, on experimental visceral hypersensitivity and its mechanism.
    Hu XG; Xu D; Zhao Y; Yang XB; Meng J; Shen H; Guo J
    Biol Pharm Bull; 2009 Jun; 32(6):1075-9. PubMed ID: 19483318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
    Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
    Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
    Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
    World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
    Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
    Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation.
    Li J; Cui H; Cai Y; Lin J; Song X; Zhou Z; Xiong W; Zhou H; Bian Y; Wang L
    Front Pharmacol; 2018; 9():1110. PubMed ID: 30323765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
    Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
    World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
    Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
    J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor.
    Hu X; Zhang X; Han B; Bei W
    BMC Complement Altern Med; 2013 Oct; 13():246. PubMed ID: 24088410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome.
    Mao Q; Shi L; Wang ZG; Luo YH; Wang YY; Li X; Lu M; Ju JM; Xu JD; Kong M; Zhou SS; Shen MQ; Li SL
    J Ethnopharmacol; 2017 Apr; 201():123-135. PubMed ID: 28263849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings.
    Xiao HT; Zhong L; Tsang SW; Lin ZS; Bian ZX
    Am J Chin Med; 2015; 43(1):1-23. PubMed ID: 25579759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Weichang Anwan on NO and 5-HT in blood serum, SP and MC in colon in IBS-D rats].
    Hu R; Tang F
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(23):3073-7. PubMed ID: 20222427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
    Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
    Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating effect of TongXie-YaoFang on colonic epithelial secretion
    Yang C; Xiong Y; Zhang SS; An FM; Sun J; Zhang QL; Zhan Q
    World J Gastroenterol; 2016 Dec; 22(48):10584-10591. PubMed ID: 28082810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.